Saruplase
![Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set](http://data.docslib.org/img/264x/135084d885a0ce0d8ef8f9f83426c79a.webp)
Top View
- (12) United States Patent (10) Patent No.: US 8,637,524 B2 Rao Et Al
- Subarachnoid Haemorrhage
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Thrombolytic Therapy and Equivalence Trials*
- (12) United States Patent (Lo) Patent No.: US 8,480,637 B2
- Project SCYLLA
- Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
- Marrakesh Agreement Establishing the World Trade Organization
- WHO Drug Information Vol. 11, No. 3, 1997
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- Subject Index
- Thromboseprophylaxe Mit Xabanen
- Customs Tariff - Schedule
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Pharmaceutical Compositions Comprising Prasugrel And
- ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
- Pharmaabkommen A1 E
- RESTRICTED ACCORD GENERAL SUR LES TARIFS TAR/W/87/Rev.L 16 Juin 1994 DOUANIERS ET LE COMMERCE Distribution Limitée Comité